(2'R,5aR,7aR,8R,9S,11aR,11bR)-9-[(S)-furan-3-yl-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-5,5,7a,9,11b-pentamethyl-3,7-dioxospiro[6,10,11,11a-tetrahydro-5aH-benzo[g][2]benzoxepine-8,3'-oxirane]-2'-carboxylic acid

Details

Top
Internal ID 6ab8a729-f999-4af8-99a1-c8f11d86d240
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Triterpenoids > Limonoids
IUPAC Name (2'R,5aR,7aR,8R,9S,11aR,11bR)-9-[(S)-furan-3-yl-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-5,5,7a,9,11b-pentamethyl-3,7-dioxospiro[6,10,11,11a-tetrahydro-5aH-benzo[g][2]benzoxepine-8,3'-oxirane]-2'-carboxylic acid
SMILES (Canonical) CC1(C2CC(=O)C3(C(C2(C=CC(=O)O1)C)CCC(C34C(O4)C(=O)O)(C)C(C5=COC=C5)OC6C(C(C(C(O6)CO)O)O)O)C)C
SMILES (Isomeric) C[C@]1(CC[C@@H]2[C@]3(C=CC(=O)OC([C@@H]3CC(=O)[C@]2([C@@]14[C@@H](O4)C(=O)O)C)(C)C)C)[C@H](C5=COC=C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O
InChI InChI=1S/C32H42O13/c1-28(2)18-12-19(34)31(5)17(29(18,3)9-7-20(35)44-28)6-10-30(4,32(31)25(45-32)26(39)40)24(15-8-11-41-14-15)43-27-23(38)22(37)21(36)16(13-33)42-27/h7-9,11,14,16-18,21-25,27,33,36-38H,6,10,12-13H2,1-5H3,(H,39,40)/t16-,17-,18+,21-,22+,23-,24+,25+,27+,29-,30+,31+,32-/m1/s1
InChI Key MXZVBPOYCKIXHN-FNBRAXOMSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C32H42O13
Molecular Weight 634.70 g/mol
Exact Mass 634.26254139 g/mol
Topological Polar Surface Area (TPSA) 206.00 Ų
XlogP 0.80
Atomic LogP (AlogP) 1.27
H-Bond Acceptor 12
H-Bond Donor 5
Rotatable Bonds 6

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2'R,5aR,7aR,8R,9S,11aR,11bR)-9-[(S)-furan-3-yl-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-5,5,7a,9,11b-pentamethyl-3,7-dioxospiro[6,10,11,11a-tetrahydro-5aH-benzo[g][2]benzoxepine-8,3'-oxirane]-2'-carboxylic acid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7630 76.30%
Caco-2 - 0.8506 85.06%
Blood Brain Barrier - 0.5000 50.00%
Human oral bioavailability - 0.7286 72.86%
Subcellular localzation Mitochondria 0.7663 76.63%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.7545 75.45%
OATP1B3 inhibitior + 0.8404 84.04%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.6750 67.50%
BSEP inhibitior + 0.6005 60.05%
P-glycoprotein inhibitior + 0.7001 70.01%
P-glycoprotein substrate + 0.5647 56.47%
CYP3A4 substrate + 0.7053 70.53%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8752 87.52%
CYP3A4 inhibition - 0.6221 62.21%
CYP2C9 inhibition - 0.7266 72.66%
CYP2C19 inhibition - 0.8367 83.67%
CYP2D6 inhibition - 0.9313 93.13%
CYP1A2 inhibition - 0.8305 83.05%
CYP2C8 inhibition + 0.6198 61.98%
CYP inhibitory promiscuity - 0.8832 88.32%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.6386 63.86%
Eye corrosion - 0.9887 98.87%
Eye irritation - 0.9127 91.27%
Skin irritation - 0.6947 69.47%
Skin corrosion - 0.9268 92.68%
Ames mutagenesis - 0.7140 71.40%
Human Ether-a-go-go-Related Gene inhibition + 0.6652 66.52%
Micronuclear - 0.7200 72.00%
Hepatotoxicity - 0.5926 59.26%
skin sensitisation - 0.8814 88.14%
Respiratory toxicity + 0.7222 72.22%
Reproductive toxicity + 0.7444 74.44%
Mitochondrial toxicity + 0.6500 65.00%
Nephrotoxicity - 0.8466 84.66%
Acute Oral Toxicity (c) I 0.4456 44.56%
Estrogen receptor binding + 0.7312 73.12%
Androgen receptor binding + 0.7753 77.53%
Thyroid receptor binding + 0.5408 54.08%
Glucocorticoid receptor binding + 0.7807 78.07%
Aromatase binding + 0.6963 69.63%
PPAR gamma + 0.7069 70.69%
Honey bee toxicity - 0.7552 75.52%
Biodegradation - 0.8250 82.50%
Crustacea aquatic toxicity - 0.6450 64.50%
Fish aquatic toxicity + 0.9773 97.73%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.55% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.44% 96.09%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 90.53% 85.14%
CHEMBL221 P23219 Cyclooxygenase-1 90.44% 90.17%
CHEMBL2581 P07339 Cathepsin D 90.43% 98.95%
CHEMBL5608 Q16288 NT-3 growth factor receptor 88.33% 95.89%
CHEMBL3137262 O60341 LSD1/CoREST complex 88.23% 97.09%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 87.97% 94.45%
CHEMBL3476 O15111 Inhibitor of nuclear factor kappa B kinase alpha subunit 87.49% 95.83%
CHEMBL1293249 Q13887 Kruppel-like factor 5 87.39% 86.33%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 86.82% 95.56%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 84.99% 94.00%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 83.68% 99.23%
CHEMBL3524 P56524 Histone deacetylase 4 81.95% 92.97%
CHEMBL1806 P11388 DNA topoisomerase II alpha 81.87% 89.00%
CHEMBL2335 P42785 Lysosomal Pro-X carboxypeptidase 81.18% 100.00%
CHEMBL4227 P25090 Lipoxin A4 receptor 80.39% 100.00%
CHEMBL5028 O14672 ADAM10 80.11% 97.50%

Cross-Links

Top
PubChem 53363753
NPASS NPC225343